Ludwig to rename Revealia, plans 2024 launch of cancer screening test

LUDWIG ENTERPRISES, INC.

Majority shareholders approved name change to Revealia, Inc., pending FINRA approval.
Plans to launch Revealia cancer screening test (noninvasive cheek swab) to DTC market in 2024.
Intends to apply for OTCQB listing as step toward NASDAQ or CBOE listing.
Over 3000 mRNA samples collected from 40+ U.S. clinics; uses AI for statistical analysis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.